Exclusive worldwide license agreement signed with the University of California at San Diego for two new, novel oxime drug technologies. June 18, 2014 • admin • General News, Pharmaceuticals Read More »
Countervail Corporation presents significant results of i.m. dosed AverTox (galantamine) for improved survival from exposure to lethal levels of soman at the CounterACT Symposium held in Denver Colorado. June 7, 2014 • admin • Funding, General News Read More »